ArticlePharmaceutics2023

Comprehensive Assessment of Pharmacokinetics, Pharmacodynamics, and Tolerability of Ligelizumab in Healthy Volunteers and Patients with Chronic Spontaneous Urticaria to Optimize Its Subcutaneous Delivery System.

Yan Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.